Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Withdrawn 1Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 16Burkitt Lymphoma 15Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Graft vs Host Disease 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Chronic-Phase 7Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Congenital Abnormalities 6Breast Neoplasms 6Blast Crisis 6Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Immunoblastic 5Dendritic Cell Sarcoma, Interdigitating 5Urinary Bladder Neoplasms 4

Interventions

fludarabine phosphate 5Cyclophosphamide 4Whole-Body Irradiation 3Cyclosporine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3fludarabine 2Stem Cell Transplantation 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Hydroxyurea 2Busulfan 2Antilymphocyte Serum 2ruxolitinib 1nelarabine 1fresolimumab 1arsenous acid 1Watchful Waiting 1Thiotepa 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1RG7388 1Phlebotomy 1Oxycodone 1Observation 1Nivolumab 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Polycythemia Vera × Methotrexate × Clear all
NCT00005641 2012-12-11

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Graft vs Host Disease, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡